From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI

Expert Review of Medical Devices
Erhan TenekeciogluPatrick W Serruys

Abstract

Drug eluting stents and particularly the fully bioresorbable drug-eluting scaffolds herald a new era in percutaneous treatment of coronary artery disease. There has been tremendous progress in drug eluting stents with fully biodegradable coating polymers and polymer-free devices with reservoir technology planting the anti-proliferative drug. Despite significant decreases in in-stent restenosis rates with drug eluting stents, limitations still remain before we are able to develop fully bioresorbable scaffolds. Enhanced mechanical flexibility that provides superior conformability to the vessel wall, resumption of the vasoreactivity in the follow-up period and improving visualization on non-invasive imaging modalities are some of the supremacies of the fully bioresorbable scaffolds. In this review, we aim to give a general view on the latest developments in metallic drug eluting stents and fully bioresorbable scaffolds.

References

Dec 19, 1998·Journal of the American College of Cardiology·R S SchwartzD R Holmes
Jan 18, 2005·Journal of the American College of Cardiology·Jean-Jacques GoyCharles Seydoux
Feb 1, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Rainer WesselyAlbert Schömig
Aug 18, 2005·The New England Journal of Medicine·Alban DibraUNKNOWN ISAR-DIABETES Study Investigators
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Adnan KastratiAlbert Schömig
Jan 5, 2006·Circulation·Julinda MehilliUNKNOWN Intracoronary Stenting and Angiographic Restenosis--Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investi
Feb 24, 2006·JAMA : the Journal of the American Medical Association·Marie-Claude MoriceUNKNOWN REALITY Trial Investigators
Sep 14, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ron WaksmanAxel Haverich
Oct 25, 2006·Circulation·Young-Hak KimUNKNOWN Long-DES-II Study Investigators
Feb 14, 2007·The New England Journal of Medicine·Bo LagerqvistUNKNOWN SCAAR Study Group
Feb 14, 2007·The New England Journal of Medicine·Gregg W StoneMartin B Leon
Jun 5, 2007·Lancet·Raimund ErbelUNKNOWN PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators
Jul 31, 2007·Journal of the American College of Cardiology·Lisette Okkels JensenLeif Thuesen
Dec 19, 2007·Journal of Interventional Cardiology·Ron WaksmanFermin O Tio
Jul 25, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Refat JabaraKeith Robinson
Jul 26, 2008·Journal of the American College of Cardiology·Michael JonerRenu Virmani
Jul 11, 2009·Journal of the American College of Cardiology·Yoshinobu OnumaUNKNOWN Interventional Cardiologists of the Thoraxcenter (2000 to 2007)
Oct 28, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ian T MeredithUNKNOWN ENDEAVOR I Investigators
May 7, 2010·The New England Journal of Medicine·Gregg W StoneUNKNOWN SPIRIT IV Investigators
Sep 10, 2010·Journal of the American College of Cardiology·Scot Garg, Patrick W Serruys
Oct 5, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Nicolaus ReifartKiriakos Giokoglu
Oct 5, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Yosinobu OnumaRichard Rapoza
Nov 4, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Jean FajadetLaura Mauri

❮ Previous
Next ❯

Citations

Nov 21, 2016·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Yao-Jun ZhangYa-Ling Han
Dec 28, 2018·Advanced Materials·Yueqi ZhuWenguo Cui
Jan 8, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jasvinder SinghNeetu Singh
Jul 8, 2019·ACS Biomaterials Science & Engineering·Tae Ho KimJin Woo Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Neville KukrejaPatrick W Serruys
JAMA : the Journal of the American Medical Association
Fernando Alfonso
© 2022 Meta ULC. All rights reserved